JESSICA HEDRICK: Open Payments
NPI 1295775849 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,583 in 86 payments from 27 companies in 2025. Trend: 2023 $1,944 · 2024 $1,676 · 2025 $1,583
Food & beverage: $1,583
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $293 |
| ABBVIE INC. | 13 | $244 |
| Lilly USA, LLC | 9 | $144 |
| PFIZER INC. | 6 | $98 |
| Axsome Therapeutics, Inc. | 5 | $92 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $84 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $77 |
| Abbott Laboratories | 2 | $59 |
| Otsuka America Pharmaceutical, Inc. | 2 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $53 |
Products named: Wegovy, MOUNJARO, QULIPTA, JARDIANCE, Ozempic, UBRELVY, Kerendia, VRAYLAR.
Industry payments across NC — which companies pay providers there.
